XML 27 R17.htm IDEA: XBRL DOCUMENT v3.5.0.2
C. STOCKHOLDERS EQUITY (Tables)
 9 Months Ended
Jun. 30, 2016
C. Stockholders Equity Tables  
Stock options, stock bonuses and compensation granted by the Company

Stock options, stock bonuses and compensation granted by the Company as of June 30, 2016 are as follows:

 

Name of Plan   Total Shares Reserved Under Plans     Shares Reserved for Outstanding Options     Shares Issued     Remaining Options/Shares Under Plans  
                         
Incentive Stock Options Plans     1,960,000       1,685,966       N/A       11,334  
Non-Qualified Stock Option Plans     7,680,000       6,005,721       N/A       1,062,861  
Stock Bonus Plans     3,594,000       N/A       2,562,950       1,030,223  
Stock Compensation Plan     3,350,000       N/A       1,767,047       1,549,905  
Incentive Stock Bonus Plan     16,000,000       N/A       15,600,000       400,000  

 

   Stock options, stock bonuses and compensation granted by the Company as of September 30, 2015 are as follows:

 

Name of Plan   Total Shares Reserved Under Plans     Shares Reserved for Outstanding Options     Shares Issued     Remaining Options/Shares Under Plans  
                         
Incentive Stock Option Plans     1,960,000       1,690,665       N/A       6,635  
Non-Qualified Stock Option Plans     7,680,000       5,849,103       N/A       1,219,479  
Bonus Plans     3,594,000       N/A       1,643,714       1,949,459  
Stock Compensation Plan     3,350,000       N/A       1,423,999       1,892,950  
Incentive Stock Bonus Plan     16,000,000       N/A       15,600,000       400,000  

 

 

Stock option activity:

 

    Nine Months Ended June 30,  
     2016      2015  
Granted     210,000       803,700  
Forfeited     55,998       137,249  

 

    Three Months Ended June 30,  
     2016      2015  
Granted     0       801,700  
Forfeited     5,000       27,833  

 

No shares of restricted stock were forfeited from the Incentive Stock Bonus Plan during the nine and three months ended June 30, 2016. During the nine and three months ended June 30, 2015, 100,000 and 0 shares, respectively, of non-vested restricted stock were forfeited.
Schedule of employees and non-employees stock compensation

Stock-Based Compensation Expense

 

    Nine Months Ended June 30,  
    2016     2015  
Employees   $ 1,263,662     $ 4,570,999  
Non-employees   $ 618,890     $ 437,729  

 

    Three months Ended June 30,  
    2016     2015  
Employees   $ 418,562     $ 619,145  
Non-employees   $ 146,830     $ 137,600  

 
Derivative Liabilities, Warrants and Other Options

 

Warrant   Issue Date   Shares Issuable upon Exercise of Warrant     Exercise Price   Expiration Date   Refer-ence  
                         
Series R   12/6/12     2,625,000     $ 4.00   12/6/16     1  
Series S   10/11/13 -10/24/14     25,928,010     $ 1.25   10/11/18     1  
Series U   4/17/14     445,514     $ 1.75   10/17/17     1  
Series V   5/28/15     20,253,164     $ 0.79   5/28/20     1  
Series W   10/28/15     17,223,248     $ 0.67   10/28/20     1  
Series Z   5/23/16     6,600,000     $ 0.55   11/23/21     1  
Series ZZ   5/23/16     500,000     $ 0.55   5/18/21     1  
Series X   1/13/16     3,000,000     $ 0.37   1/13/21     2  
Series Y   2/15/16     650,000     $ 0.48   2/15/21     2  
Series N   8/18/08     2,844,627     $ 0.53   8/18/17        
Series P   2/10/12     590,001     $ 4.50   3/6/17        
Consultants   12/2/11- 1/1/16     440,000     $ 0.37- $3.50   10/27/16- 12/31/18     3  

 

 

11

 

  

The following chart presents the derivative liabilities, warrants and other options outstanding at September 30, 2015:

 

Warrant   Issue Date   Shares Issuable upon Exercise of Warrants     Exercise Price   Expiration Date   Refer-ence  
                         
Series N   8/18/08     2,844,627       0.53   8/18/17      
Series Q   6/21/12     1,200,000       5.00   12/22/15     1  
Series R   12/6/12     2,625,000       4.00   12/6/16     1  
Series S   10/11/13- 10/24/14     25,928,010       1.25   10/11/18     1  
Series U   4/17/14     445,514       1.75   10/17/17     1  
Series V   5/28/15     20,253,164       0.79   5/28/20     1  
Series P   2/10/12     590,001       4.50   3/6/17        
Consultants   10/14/05 – 7/1/15     238,000       0.66 – 20.00   10/14/15 - 6/30/18     3  
Tabular disclosure of derivative liabilities at fair value

The table below presents the derivative instruments and their respective balances at the balance sheet dates:

 

    June 30, 2016     September 30, 2015  
Series S warrants   $ 3,930,686     $ 7,363,555  
Series U warrants     4,455       44,551  
Series V warrants     3,443,038       6,278,481  
Series W warrants     3,557,971       -  
Series Z warrants     1,756,982       -  
Series ZZ warrants     129,920       -  
                 
Total derivative liabilities   $ 12,823,052     $ 13,686,587  
Schedule Of Gains and (Losses) on Derivative Liabilities

The gains on the derivative instruments are as follows:

 

    Nine Months Ended June 30,  
    2016     2015  
Series A through E warrants   $ -     $ 6,105  
Series H warrants     -       12,000  
Series Q warrants     -       12,000  
Series R warrants     -       131,250  
Series S warrants     3,432,869       472,487  
Series U warrants     40,096       74,352  
Series V warrants     2,835,443       1,100,760  
Series W warrants     1,502,800       -  
Series Z warrants     210,848       -  
Series ZZ warrants     15,918       -  
                 
Gain on derivative instruments   $ 8,037,974     $ 1,808,954  

 

    Three Months Ended June 30,  
    2016     2015  
Series H warrants   $ -     $ 12,000  
Series Q warrants     -       12,000  
Series R warrants     -       105,000  
Series S warrants     285,208       3,111,361  
Series U warrants     13,366       87,659  
Series V warrants     1,012,658       1,100,760  
Series W warrants     970,746          
Series Z warrants     210,848       -  
Series ZZ warrants     15,918       -  
                 
Gain on derivative instruments   $ 2,508,744     $ 4,428,780